LMDX News and Press, LumiraDx Limited From 07/21/22

LumiraDx Announces Pricing of Public Offering of Common Shares and Concurrent Private Placement PR Newswire LONDON , July 21, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today annou...

Gainers: Sidus Space ( SIDU ) +34% . DermTech ( DMTK ) +25% . Eos Energy Enterprises ( EOSE ) +24% . NuCana ( NCNA ) +21% . Power REIT ( PW ) +21% . Apellis Pharmaceuticals ( APLS ) +20% . Silvergate ( SI ) ...

Gainers: Apellis Pharmaceuticals APLS +22% . Neuronetics STIM +17% . Nyxoah ( NYXH ) +17% . Celyad Oncology ( CYAD ) +8% . NuCana ( NCNA ) +7% . Losers: High Tide HITI -21% . Ultragenyx Pharmaceutical ( RARE ...

LumiraDx ( NASDAQ: LMDX ) plunged 10% in premarket after it commenced an underwritten public offering of 40M shares; underwriters granted 30-day option to purchase up to an additional 6M shares. Offer size, terms have not yet been decided. Net proceeds along w...

LumiraDx Announces Proposed Public Offering of Common Shares PR Newswire LONDON , July 19, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced that it has commenced an underwritt...

Qudian ( QD ) +57% food progress report. INTELLIGENT LIVING ( ILAG ) +39% . Eton Pharmaceuticals ( ETON ) +22% on FDA approval of seizure therapy. Advent Technologies Holdings ( ADN ) +19% stock surges as EU ratifies Green HiPo project...

The Bill & Melinda Gates Foundation has picked up a 7.4% passive stake in LumiraDx ( NASDAQ: LMDX ), sending shares of the small-cap diagnostics company surging ~23% after hours. The passive stake was disclosed in a 13G filing with the U.S. SEC on Friday . ...

LumiraDx (NASDAQ:LMDX) on Thursday said it had got the European Commission's CE Mark for its Amira System, a low-cost COVID-19 test. The CE marking signifies that products sold in the European Economic Area have been "assessed to meet high safety, health, and environmental prot...

LumiraDx Achieves CE Mark for COVID-19 Antigen Test on Amira, its New Low-Cost Testing System PR Newswire Next-generation antigen test system built on more than eight years of research and backed by industry leading microfluidic experts The Amira System includes th...

Gainers: DBV Technologies (DBVT) +21%. Rubius Therapeutics (RUBY) +20%. Annovis Bio (ANVS) +17%. LumiraDx (LMDX) +16%. CTI BioPharma (CTIC) +15%. Losers: Rigel Pharmaceuticals (RIGL) -48%. Cosmos (COSM) -13%. Accelerate Diagnostics (AXDX) ...